Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. - Wikidata - awgldk - TriplyDB

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

http://www.wikidata.org/entity/Q33349719

about

Immune thrombocytopenia Contemporary management of primary immune thrombocytopenia in adults Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.Autoimmune thrombocytopenia.Management of patients with refractory immune thrombocytopenic purpura.Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.New insights and therapeutics for immune-mediated thrombocytopenia.High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura.High dose dexamethasone therapy shows better responses in acute immune thrombocytopenia than in chronic immune thrombocytopenia.Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.Long-term management of chronic immune thrombocytopenic purpura in adults.Eltrombopag for the treatment of idiopathic thrombocytopenic purpura.Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.Successful surgical treatment and chemotherapy for ovarian cancer in a patient with idiopathic thrombocytopenic purpura.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Current treatment options for primary immune thrombocytopenia.Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.Therapeutic options for immune-mediated thrombocytopenia.[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].Sequence of treatments for adults with primary immune thrombocytopenia.Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia.High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy.Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia.Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia Immune thrombocytopenia -- what are the new treatment options?Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.Contemporary treatment of immune thrombocytopenia.Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths Absolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia.Immune thrombocytopenia: recent progress in pathophysiology and treatment.The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment

P2860

Q26830918-9E8F976E-95F5-4272-A715-F450A46E7FED Q26853680-4636CD62-D5E4-429F-96BA-95973EDE5539 Q26999394-8AFC8A6B-B847-4B26-B48F-67BC38BBC116 Q33359740-E0354ABB-511C-4E66-BEE6-F7C5BB512D40 Q33367861-3CE34C11-3E3D-4079-A2DC-BC6ED34D03C0 Q33372113-A243E4F8-119E-42DC-819E-564103D79A22 Q33376201-FDB633D3-9A78-457E-B714-E0CBE9AD214C Q33377901-84B33BE4-643F-4AFE-9B63-C1447EE98C77 Q33386471-EA1FEA54-0DF9-46A0-A2A5-DEDE921502F9 Q33388561-7275ED5F-9E30-40FE-87DC-F15B087413EE Q33390001-73152924-A7CF-4729-B24E-2A970E68964D Q33392406-A5D39892-53F3-49AD-8AEF-4B5F1BCBC520 Q33392610-DC075DB5-7626-49CF-8A36-658C8133D333 Q33392852-54F254AC-E476-40A0-BE30-D503A218A1F3 Q33392868-23291211-CA8D-437B-9F06-B7C70611A782 Q33393144-514F1B3C-731F-428D-AA96-DA28E8CFF474 Q33393732-4F1528AA-9BBB-4302-866B-47AA6DA3789A Q33394149-31F70EDD-C2DA-42CB-B8EA-D39004E2E236 Q33399398-ED456BCB-6E01-4E75-A1B1-8C24C68EE8F1 Q33399601-9E98B508-87A4-44E6-B902-1F78A70AB651 Q33400018-768F03BC-3B3D-40D8-AD9B-AF2607125221 Q33400072-3E4313B6-A892-44AC-97A6-761C3F6BAC25 Q33400722-08E97F5B-0442-4C76-B0FC-509A90EAC2F5 Q33401624-E81EB1D4-BEB1-4BAF-8A76-6D05AFB74486 Q33405498-89993599-D102-4C82-89A9-103ABE8A0294 Q33406310-03973F31-62F9-46BE-B706-013BCC4E2E53 Q33406838-3EE867BD-59CD-4C37-8EB0-A7573AC639CA Q33406925-42725492-90AF-4D2C-8ED1-6C98C7999E43 Q33407096-A06C1E29-932D-4F3E-9AA1-AFA109AF1B2C Q33407451-23322983-6CCA-49F7-A56E-838E482A3E28 Q33407802-F255C766-E152-42AC-8392-5FB9639D5EE1 Q33407822-9FEC3E94-34F9-4722-9915-EA692BFC9D6A Q33410653-AA0727E8-BE92-4DE3-8CF6-41AF8456A3C8 Q33412266-4E239FF6-06A3-4B47-862B-DA7804A9BA2C Q33412766-BE036F3B-7F1F-4DD3-843E-85E97EA258B2 Q33413896-D93B2796-E6C6-49BE-8BB5-409163B51868 Q33414420-56792345-515F-4689-80A9-0BD583D4723E Q33414722-6C843E41-70BB-49B2-8F13-BE7878869294 Q33423573-ABC80808-F27B-421D-8EE7-49EA76945933 Q33423890-D21DA234-0D25-4FEE-BF27-B0B07B34F174

P2860

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

http://www.wikidata.org/entity/Q33349719

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@ast

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@en

type

label

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@ast

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@en

prefLabel

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@ast

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@en

P1433

Q33349719-090FCDE1-EDB1-4944-B9CF-0743872FE6A8

P1476

Q33349719-025629DF-9614-423C-8D86-CA2AADC32F04

P2093

Q33349719-1C00E988-4D9D-431C-8E53-EBD5C9CBD801

Q33349719-3500A9C1-BD13-46E3-8189-7B173F8CAB9A

Q33349719-54EF2BAD-0CC0-42D4-A025-CCCE4ED929B2

Q33349719-85F16205-50A7-4FD9-9EB6-0C911734E3F3

Q33349719-9E16E308-0BBC-4B85-91C4-3CF6D4A1162B

Q33349719-A381EE60-6210-442A-8588-204038D7E83A

Q33349719-D7474BC7-832D-47FA-AE9B-6388F880801B

Q33349719-EC4C24BB-31E5-4EFD-B8E3-D7EA80C91261

P304

Q33349719-DFED1AF1-964E-4A0B-B530-C61EC9EC11DE

P31

Q33349719-8764BCC6-ECD1-4D54-A2D5-8C5E7F215F0C

P356

Q33349719-94A52EB8-E4E0-4EC8-8B3A-E7C5FAA039D7

P407

Q33349719-C1D4C60D-DCE5-4CAB-B5DE-8D49D6DAABB2

P433

Q33349719-F4BA4DA1-E561-4491-AA03-20C01FECA191

P478

Q33349719-9DAA8083-FD12-4DA0-8445-477FA845638B

P577

Q33349719-ED9675E6-3D3A-4A30-9F5B-C3825646B9CA

P698

Q33349719-56112822-102B-400B-8A82-59A28FBB6497

P921

Q33349719-44BA7184-4D87-4920-8369-FE37BCCAAE22

Q33349719-D88C4213-795A-4308-9A81-61053B2F0F8B

P356

P1433

The New England Journal of Medicine

P1476

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

@en

P2093

Chung Hin Chui

http://www.w3.org/2001/XMLSchema#string

Fung Yi Lau

http://www.w3.org/2001/XMLSchema#string

Gregory Cheng

http://www.w3.org/2001/XMLSchema#string

Natalie P H Chan

http://www.w3.org/2001/XMLSchema#string

Raymond S M Wong

http://www.w3.org/2001/XMLSchema#string

Wai Shan Wong

http://www.w3.org/2001/XMLSchema#string

Yannie O Y Soo

http://www.w3.org/2001/XMLSchema#string

Yunfeng Cheng

http://www.w3.org/2001/XMLSchema#string

P304

831-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA030254

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12944568

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia